Recent News from ME Research UK, Action for ME and the ME Association.
Former Worcestershire MP’s involvement
ME Research UK (MERUK) give ME/CFS Delivery Plan detailed announcement.
Winter 2024/2025 Publication announced for ME/CFS Delivery Plan
13 August 2024
Baroness Scott of Needham Market tabled 3 linked questions on 29 July 2024 asking the Dept of Health and Social Care to provide - an update on publication of the cross-Government ME/CFS Delivery Plan (UIN HL452), whether the Delivery Plan will include provision for hospital treatment and full consideration of how to safely prevent malnutrition in very severe ME (UIN HL453), and querying what assessment the government has made of the percentage of the research budget allocated for ME/CFS and Long Covid, and whether they plan to increase this amount (UIN HL454).
Answering on behalf of the government in a combined response, Baroness Merton (Parliamentary Under-Secretary at the Department of Health and Social Care) revealed that -
A consultation was run in 2023 on the interim delivery plan for myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS). In the World ME Day Westminster Hall debate in May 2024, the current Parliamentary Under-Secretary of State for Public Health and Prevention pushed for the publication of a response to the consultation. It is now a priority for the Department, and it is our intention to publish a response in the coming months. The consultation responses, along with continued close engagement with stakeholders, will inform the development of the Final Delivery Plan, which we aim to publish in the winter of 2024/25.
No specific assessment has been made of the proportion of the research budget allocated for ME/CFS or long COVID. Over the last five years, the Department, through the National Institute for Health and Care Research (NIHR), has allocated £6.64 million of funding to support 10 research projects, including the £3.2 million DecodeME study, co-funded with the Medical Research Council. Over the same period, the NIHR and UK Research and Innovation have awarded over £50 million for long COVID research. The NIHR remains committed to funding high-quality research to better understand the causes and health impacts of ME/CFS and long COVID, and to identify and evaluate new treatments and interventions.
It is not usual practice for the NIHR to ring-fence funds for particular topics or conditions. The NIHR welcomes funding applications for research into any aspect of human health, including ME/CFS and long COVID. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.
What does this tell us?
Plus ça change
This group believes that the MRC should be more open-minded in their evaluation of proposals for biomedical research into CFS/ME and that, in order to overcome the perception of bias in their decisions, they should assign at least an equivalent amount of funding (£11 million) to biomedical research as they have done to psychosocial research. It can no longer be left in a state of flux and these patients or potential patients should expect a resolution of the problems with only an intense research programme can help resolve. It is an illness whose time has certainly come.
Group on Scientific Research into ME Report (Gibson Report) Nov 2006
Worcestershire ME Social Group’s blog, and 'About ME' information.
The late Dr Richard Taylor, MP for Wyre Forest, (from 2001 to 2010), was Vice chairman of this all-party Group for Scientific Research into ME (GRSME).
Worcestershire ME Social Group’s blog,
World ME Day Sunday 12 May and ME/CFS Awareness Week 6 - 12 May
7/5/2024
World ME Day Debate lead by Sir Sajid Javid, MP for Bromsgrove (2010 - 2024), was held on the first day of ME/CFS Awareness Month in Westminster Hall, Houses of Parliament. “Introducing the topic, the former Secretary of State for Health and Social Care and impetus behind the Delivery Plan process,”
News from Action for ME (AfME).
Labour commits to publish full Delivery Plan on ME/CFS
August 08, 2024
Statement by Andrew Gwynne MP, Parliamentary Under-Secretary of State for Public Health and Prevention.
In response to concerns from the ME community relating to the publication of the full Delivery Plan on ME/CFS, following the Government's response to a question by Baroness Scott of Needham Market on 29 July, Andrew Gwynne MP has confirmed Labour's commitment to publishing the full Delivery Plan on ME/CFS:
"It isn’t being delayed again… I’ve asked my officials to publish the plan, which they will now do. The last government sadly stalled the process. Officials are now putting everything together and I should have something to see very soon pending publication."
In response to Andrew Gwynne MP's statement, Action for M.E. CEO, Sonya Chowdhury, said:
"We are delighted to hear the Labour Government's commitment to publishing the full Delivery Plan on ME/CFS and know this announcement will be met with a level of relief from the ME community. It is now essential that, once published, the commitments made to people affected by ME within the Plan are implemented as a priority, including urgent action to address the lack of research funding into the condition, and we look forward to working with the Labour Government to ensure this happens."
Parliamentary Question: Baroness Scott of Needham Market, 29 July 2024
“To ask His Majesty's Government what assessment they have made of the percentage of the research budget allocated for myalgic encephalomyelitis and Long Covid, and whether they plan to increase this amount.”
Answer: Baroness Merron, 06 August 2024
“A consultation was run in 2023 on the interim delivery plan for myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS). In the World ME Day Westminster Hall debate in May 2024, the current Parliamentary Under-Secretary of State for Public Health and Prevention pushed for the publication of a response to the consultation. It is now a priority for the Department, and it is our intention to publish a response in the coming months. The consultation responses, along with continued close engagement with stakeholders, will inform the development of the Final Delivery Plan, which we aim to publish in the winter of 2024/25.
“No specific assessment has been made of the proportion of the research budget allocated for ME/CFS or long COVID. Over the last five years, the Department, through the National Institute for Health and Care Research (NIHR), has allocated £6.64 million of funding to support 10 research projects, including the £3.2 million DecodeME study, co-funded with the Medical Research Council. Over the same period, the NIHR and UK Research and Innovation have awarded over £50 million for long COVID research. The NIHR remains committed to funding high-quality research to better understand the causes and health impacts of ME/CFS and long COVID, and to identify and evaluate new treatments and interventions.
“It is not usual practice for the NIHR to ring-fence funds for particular topics or conditions. The NIHR welcomes funding applications for research into any aspect of human health, including ME/CFS and long COVID. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.”
Plus. Information from the ME Association(MEA)
Labour government commits to publishing the final delivery plan on ME/CFS
August 7, 2024
Parliamentary Question: Baroness Scott of Needham Market, Liberal Democrat, 29 July 2024
“To ask His Majesty's Government what assessment they have made of the percentage of the research budget allocated for myalgic encephalomyelitis and Long Covid, and whether they plan to increase this amount.”
Answer: Baroness Merron, Labour, 06 August 2024:
“A consultation was run in 2023 on the interim delivery plan for myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS). In the World ME Day Westminster Hall debate in May 2024, the current Parliamentary Under-Secretary of State for Public Health and Prevention pushed for the publication of a response to the consultation. It is now a priority for the Department, and it is our intention to publish a response in the coming months. The consultation responses, along with continued close engagement with stakeholders, will inform the development of the Final Delivery Plan, which we aim to publish in the winter of 2024/25.
“No specific assessment has been made of the proportion of the research budget allocated for ME/CFS or long COVID. Over the last five years, the Department, through the National Institute for Health and Care Research (NIHR), has allocated £6.64 million of funding to support 10 research projects, including the £3.2 million DecodeME study, co-funded with the Medical Research Council. Over the same period, the NIHR and UK Research and Innovation have awarded over £50 million for long COVID research. The NIHR remains committed to funding high-quality research to better understand the causes and health impacts of ME/CFS and long COVID, and to identify and evaluate new treatments and interventions.
“It is not usual practice for the NIHR to ring-fence funds for particular topics or conditions. The NIHR welcomes funding applications for research into any aspect of human health, including ME/CFS and long COVID. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.”
Previously, last month, the ME Association (MEA) stated a Parliamentary Question
July 26, 2024:
What steps does the Government plan to take to improve support for people with ME
QUESTION: Dr Rupa Huq, Labour, Eailing Central and Acton: To ask the Secretary of State for Health and Social Care, what steps he plans to take to improve support for people with myalgic encephalomyelitis.
ANSWER: Andrew Gwynne, Labour, Gorton and Denton – Parliamentary Under-Secretary of State at the Department of Health and Social Care:
“Integrated care boards (ICBs) are responsible for commissioning specialist myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), services that meet the needs of their population, subject to local prioritisation and funding. The process of commissioning services should take into account best practice guidance, such as the National Institute for Health and Care Excellence’s (NICE) guidance on ME/CFS diagnosis and management, published in October 2021.
The Department funds research into ME/CFS through the National Institute for Health and Care Research (NIHR). The NIHR, together with the Medical Research Council, is funding the world’s largest genome-wide association study of ME/CFS. This £3.2 million study, termed DecodeME, will analyse samples from 25,000 people with ME/CFS to search for genetic differences that may indicate underlying causes or an increased risk of developing the condition. A decision on the next steps for ME/CFS at the national level will be taken in the coming weeks.”
MEA Comment
We have a new Labour Government and this is a recurring parliamentary question on ME/CFS with the same ministerial answer.
As per the APPG on ME announcement, we understand the need to ensure that ME is kept firmly on the agenda of the new Government and that the All-Party Parliamentary Group (APPG) on ME will play an important part in this.
The ME Association will continue to campaign for people with ME/CFS and we would urge the new Labour Government to do its very best to ensure there are no further delays in publishing the Delivery Plan on ME/CFS.
Dr Charles Shepherd,
Trustee and Hon. Medical Adviser to the ME Association.
Member of the 2018-2021 NICE Guideline Committee.
Member of the 2002 Independent Working Group on ME/CFS.
A reminder -
The Worcestershire M.E. Social Group’s "Symptoms of M.E./CFS” Information Sheet" was updated in May 2024. It is available on our website in the About M.E. section. The recent group announcement includes Symptoms and Awareness news from Action for ME (AfME),, BACME (British Association of Clinicians in ME/CFS), ME Research UK (MERUK); and the ME Association.(MEA).
Contact your local MP. Ensure your local MP is aware of the situation.
• Action for ME • Government U.K. • M.E. Association • MERUK
• MP • N.H.S.
Former Worcestershire MP’s involvement
ME Research UK (MERUK) give ME/CFS Delivery Plan detailed announcement.
Winter 2024/2025 Publication announced for ME/CFS Delivery Plan
13 August 2024
Baroness Scott of Needham Market tabled 3 linked questions on 29 July 2024 asking the Dept of Health and Social Care to provide - an update on publication of the cross-Government ME/CFS Delivery Plan (UIN HL452), whether the Delivery Plan will include provision for hospital treatment and full consideration of how to safely prevent malnutrition in very severe ME (UIN HL453), and querying what assessment the government has made of the percentage of the research budget allocated for ME/CFS and Long Covid, and whether they plan to increase this amount (UIN HL454).
Answering on behalf of the government in a combined response, Baroness Merton (Parliamentary Under-Secretary at the Department of Health and Social Care) revealed that -
A consultation was run in 2023 on the interim delivery plan for myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS). In the World ME Day Westminster Hall debate in May 2024, the current Parliamentary Under-Secretary of State for Public Health and Prevention pushed for the publication of a response to the consultation. It is now a priority for the Department, and it is our intention to publish a response in the coming months. The consultation responses, along with continued close engagement with stakeholders, will inform the development of the Final Delivery Plan, which we aim to publish in the winter of 2024/25.
No specific assessment has been made of the proportion of the research budget allocated for ME/CFS or long COVID. Over the last five years, the Department, through the National Institute for Health and Care Research (NIHR), has allocated £6.64 million of funding to support 10 research projects, including the £3.2 million DecodeME study, co-funded with the Medical Research Council. Over the same period, the NIHR and UK Research and Innovation have awarded over £50 million for long COVID research. The NIHR remains committed to funding high-quality research to better understand the causes and health impacts of ME/CFS and long COVID, and to identify and evaluate new treatments and interventions.
It is not usual practice for the NIHR to ring-fence funds for particular topics or conditions. The NIHR welcomes funding applications for research into any aspect of human health, including ME/CFS and long COVID. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.
What does this tell us?
- publication of the Delivery Plan - a process announced in May 2022 - is a ‘priority’.
- the government’s response to the consultation phase of the draft Delivery Plan will be forthcoming ‘in the coming months’.
- the full Delivery Plan will be published in the Winter but no firm date given despite the fact that publication has slid back and was initially due by the end of 2022, …. then as soon as possible in 2023 ….. and now slated for end of 2024 …. or beginning of 2025.
- NIHR continues with its sleight of hand by referencing only past 5 years of funding with its support of deCodeME whilst ignoring decades of underinvestment in biomedical research into ME/CFS and MRC’s funding of biopsychosocial research.
- Egregious underfunding of ME/CFS research when compared to long COVID.
- No comment on whether ME/CFS research funding will be increased.
- Despite decade’s long call for ring-fenced ME/CFS research funding, (cf. CMO Working Group and Gibson Report) it is confirmed that “not usual practice for the NIHR to ring-fence funds” for particular illnesses. It appears the government is oblivious to fact that both Germany and The Netherlands (28.5 million euros 10-year programme) have strategic ME/CFS research collaboratives precisely because of ring-fenced funding.
- UIN HL453 went unanswered.
Plus ça change
This group believes that the MRC should be more open-minded in their evaluation of proposals for biomedical research into CFS/ME and that, in order to overcome the perception of bias in their decisions, they should assign at least an equivalent amount of funding (£11 million) to biomedical research as they have done to psychosocial research. It can no longer be left in a state of flux and these patients or potential patients should expect a resolution of the problems with only an intense research programme can help resolve. It is an illness whose time has certainly come.
Group on Scientific Research into ME Report (Gibson Report) Nov 2006
Worcestershire ME Social Group’s blog, and 'About ME' information.
The late Dr Richard Taylor, MP for Wyre Forest, (from 2001 to 2010), was Vice chairman of this all-party Group for Scientific Research into ME (GRSME).
Worcestershire ME Social Group’s blog,
World ME Day Sunday 12 May and ME/CFS Awareness Week 6 - 12 May
7/5/2024
World ME Day Debate lead by Sir Sajid Javid, MP for Bromsgrove (2010 - 2024), was held on the first day of ME/CFS Awareness Month in Westminster Hall, Houses of Parliament. “Introducing the topic, the former Secretary of State for Health and Social Care and impetus behind the Delivery Plan process,”
News from Action for ME (AfME).
Labour commits to publish full Delivery Plan on ME/CFS
August 08, 2024
Statement by Andrew Gwynne MP, Parliamentary Under-Secretary of State for Public Health and Prevention.
In response to concerns from the ME community relating to the publication of the full Delivery Plan on ME/CFS, following the Government's response to a question by Baroness Scott of Needham Market on 29 July, Andrew Gwynne MP has confirmed Labour's commitment to publishing the full Delivery Plan on ME/CFS:
"It isn’t being delayed again… I’ve asked my officials to publish the plan, which they will now do. The last government sadly stalled the process. Officials are now putting everything together and I should have something to see very soon pending publication."
In response to Andrew Gwynne MP's statement, Action for M.E. CEO, Sonya Chowdhury, said:
"We are delighted to hear the Labour Government's commitment to publishing the full Delivery Plan on ME/CFS and know this announcement will be met with a level of relief from the ME community. It is now essential that, once published, the commitments made to people affected by ME within the Plan are implemented as a priority, including urgent action to address the lack of research funding into the condition, and we look forward to working with the Labour Government to ensure this happens."
Parliamentary Question: Baroness Scott of Needham Market, 29 July 2024
“To ask His Majesty's Government what assessment they have made of the percentage of the research budget allocated for myalgic encephalomyelitis and Long Covid, and whether they plan to increase this amount.”
Answer: Baroness Merron, 06 August 2024
“A consultation was run in 2023 on the interim delivery plan for myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS). In the World ME Day Westminster Hall debate in May 2024, the current Parliamentary Under-Secretary of State for Public Health and Prevention pushed for the publication of a response to the consultation. It is now a priority for the Department, and it is our intention to publish a response in the coming months. The consultation responses, along with continued close engagement with stakeholders, will inform the development of the Final Delivery Plan, which we aim to publish in the winter of 2024/25.
“No specific assessment has been made of the proportion of the research budget allocated for ME/CFS or long COVID. Over the last five years, the Department, through the National Institute for Health and Care Research (NIHR), has allocated £6.64 million of funding to support 10 research projects, including the £3.2 million DecodeME study, co-funded with the Medical Research Council. Over the same period, the NIHR and UK Research and Innovation have awarded over £50 million for long COVID research. The NIHR remains committed to funding high-quality research to better understand the causes and health impacts of ME/CFS and long COVID, and to identify and evaluate new treatments and interventions.
“It is not usual practice for the NIHR to ring-fence funds for particular topics or conditions. The NIHR welcomes funding applications for research into any aspect of human health, including ME/CFS and long COVID. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.”
Plus. Information from the ME Association(MEA)
Labour government commits to publishing the final delivery plan on ME/CFS
August 7, 2024
Parliamentary Question: Baroness Scott of Needham Market, Liberal Democrat, 29 July 2024
“To ask His Majesty's Government what assessment they have made of the percentage of the research budget allocated for myalgic encephalomyelitis and Long Covid, and whether they plan to increase this amount.”
Answer: Baroness Merron, Labour, 06 August 2024:
“A consultation was run in 2023 on the interim delivery plan for myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS). In the World ME Day Westminster Hall debate in May 2024, the current Parliamentary Under-Secretary of State for Public Health and Prevention pushed for the publication of a response to the consultation. It is now a priority for the Department, and it is our intention to publish a response in the coming months. The consultation responses, along with continued close engagement with stakeholders, will inform the development of the Final Delivery Plan, which we aim to publish in the winter of 2024/25.
“No specific assessment has been made of the proportion of the research budget allocated for ME/CFS or long COVID. Over the last five years, the Department, through the National Institute for Health and Care Research (NIHR), has allocated £6.64 million of funding to support 10 research projects, including the £3.2 million DecodeME study, co-funded with the Medical Research Council. Over the same period, the NIHR and UK Research and Innovation have awarded over £50 million for long COVID research. The NIHR remains committed to funding high-quality research to better understand the causes and health impacts of ME/CFS and long COVID, and to identify and evaluate new treatments and interventions.
“It is not usual practice for the NIHR to ring-fence funds for particular topics or conditions. The NIHR welcomes funding applications for research into any aspect of human health, including ME/CFS and long COVID. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.”
Previously, last month, the ME Association (MEA) stated a Parliamentary Question
July 26, 2024:
What steps does the Government plan to take to improve support for people with ME
QUESTION: Dr Rupa Huq, Labour, Eailing Central and Acton: To ask the Secretary of State for Health and Social Care, what steps he plans to take to improve support for people with myalgic encephalomyelitis.
ANSWER: Andrew Gwynne, Labour, Gorton and Denton – Parliamentary Under-Secretary of State at the Department of Health and Social Care:
“Integrated care boards (ICBs) are responsible for commissioning specialist myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), services that meet the needs of their population, subject to local prioritisation and funding. The process of commissioning services should take into account best practice guidance, such as the National Institute for Health and Care Excellence’s (NICE) guidance on ME/CFS diagnosis and management, published in October 2021.
The Department funds research into ME/CFS through the National Institute for Health and Care Research (NIHR). The NIHR, together with the Medical Research Council, is funding the world’s largest genome-wide association study of ME/CFS. This £3.2 million study, termed DecodeME, will analyse samples from 25,000 people with ME/CFS to search for genetic differences that may indicate underlying causes or an increased risk of developing the condition. A decision on the next steps for ME/CFS at the national level will be taken in the coming weeks.”
MEA Comment
We have a new Labour Government and this is a recurring parliamentary question on ME/CFS with the same ministerial answer.
As per the APPG on ME announcement, we understand the need to ensure that ME is kept firmly on the agenda of the new Government and that the All-Party Parliamentary Group (APPG) on ME will play an important part in this.
The ME Association will continue to campaign for people with ME/CFS and we would urge the new Labour Government to do its very best to ensure there are no further delays in publishing the Delivery Plan on ME/CFS.
Dr Charles Shepherd,
Trustee and Hon. Medical Adviser to the ME Association.
Member of the 2018-2021 NICE Guideline Committee.
Member of the 2002 Independent Working Group on ME/CFS.
A reminder -
The Worcestershire M.E. Social Group’s "Symptoms of M.E./CFS” Information Sheet" was updated in May 2024. It is available on our website in the About M.E. section. The recent group announcement includes Symptoms and Awareness news from Action for ME (AfME),, BACME (British Association of Clinicians in ME/CFS), ME Research UK (MERUK); and the ME Association.(MEA).
Contact your local MP. Ensure your local MP is aware of the situation.
• Action for ME • Government U.K. • M.E. Association • MERUK
• MP • N.H.S.
RSS Feed
